Concepedia

Futility Monitoring

Futility Monitoring is a statistical decision rule in adaptive experimental designs that belongs to the class of interim monitoring procedures and is distinguished by its purpose of evaluating whether continuing a trial is unlikely to yield a statistically significant or clinically meaningful result at completion.

30

Publications

1.4K

Citations

1.2K

Authors

240

Institutions

Publications per year

2017–2026

10

Parents

Publications

30

The utility of Bayesian predictive probabilities for interim monitoring of clinical trials

Benjamin R. Saville, Jason T. Connor, Gregory D. Ayers et al. · Clinical Trials · 2014 · 170 citations · Full text

, , +14

Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial

Alfredo Carrato, Anna Świeboda-Sadlej, Marzanna Staszewska-Skurczyńska et al. · Journal of Clinical Oncology · 2013 · 133 citations · Full text

, , +15

Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients

J. Wouter Jukema, R Timal, Joris I. Rotmans et al. · Circulation · 2019 · 111 citations · Full text

, , +13

Palbociclib in Patients With Pancreatic and Biliary Cancer With<i>CDKN2A</i>Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study

Tareq Al Baghdadi, Susan Halabi, Elizabeth Garrett‐Mayer et al. · JCO Precision Oncology · 2019 · 93 citations

, , +17

The futility index. An approach to the cost-effective termination of randomized clinical trials

James H. Ware, James E. Muller, Eugene Braunwald · The American Journal of Medicine · 1985 · 83 citations

, , +16

1–5 of 30

Authors

1.2K

  1. BF
    Boris Freidlin

    National Cancer Institute, United States

    5 publications · 192 citations

    5

    h-index

  2. EL
    Edward L. Korn

    National Cancer Institute, United States

    5 publications · 192 citations

    5

    h-index

  3. SH
    Susan Halabi

    Duke University, United States

    2 publications · 112 citations

    2

    h-index

  4. SB
    Sarah Burris

    University of Tennessee Health Science Center, United States

    2 publications · 62 citations

    1

    h-index

  5. DP
    David P. Looney

    U.S. Army Research Institute of Environmental Medicine, United States

    2 publications · 62 citations

    1

    h-index

1–5 of 1.2K

Institutions

240

  1. National Cancer Institute

    Bethesda, United States

    5 h-index

    9 publications

    359 citations

  2. University of California, San Francisco

    San Francisco, United States

    3 h-index

    35 publications

    1.6K citations

  3. Duke Medical Center

    Durham, United States

    2 h-index

    2 publications

    112 citations

  4. U-M Rogel Cancer Center

    Ann Arbor, United States

    2 h-index

    8 publications

    356 citations

  5. Cleveland Clinic

    Cleveland, United States

    2 h-index

    5 publications

    194 citations

  6. University of Chicago

    Chicago, United States

    2 h-index

    2 publications

    43 citations

  7. University of Colorado Denver

    Denver, United States

    2 h-index

    21 publications

    711 citations

  8. Oregon Health & Science University

    Portland, United States

    2 h-index

    15 publications

    537 citations

1–8 of 240

Venues

  1. Clinical Trials

    6 publications · 326 citations

    6

    h-index

  2. Journal of Clinical Oncology

    4 publications · 234 citations

    4

    h-index

  3. Journal of the American Geriatrics Society

    2 publications · 39 citations

    2

    h-index

  4. Circulation

    1 publications · 111 citations

    1

    h-index

  5. JCO Precision Oncology

    1 publications · 93 citations

    1

    h-index

1–5